10763942 Canada Inc.
$30,000.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- October 2, 2023 – April 30, 2024
- Reference
- nrc-cnrc:172-2023-2024-Q3-1011033
Published purpose
• Develop the scientific rationale for pipeline elements, including generation of high-quality, detailed analyses and reports to support therapeutic indication selection and pipeline progression. • Analyse market trends and competitor activities to inform business and R&D strategy and identify potential risks and opportunities. • Analyse and interpret data derived from in house and external research studies to generate high-quality reports. • Identify new business opportunities in the pharmaceutical and nutraceutical industry related to neurological diseases. • Develop and maintain relationships with key industry stakeholders, including pharmaceutical companies, academic institutions, and government agencies.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.